title: Surgical treatment of hepatocellular carcinoma originating from caudate lobe--a report of 39 cases.
abstract: The study objective was to study the therapeutic effect of surgical treatment for hepatocellular carcinoma (HCC) originating from the caudate lobe. From 1995 to 2003, caudate lobe resection was carried out for 97 cases; among them 39 were for HCC, who were divided into two groups. Group A consisted of 19 cases undergoing isolated caudatectomy, and group B consisted of 20 cases undergoing caudatectomy combined with other liver resections. The factors that might influence postoperative recovery were compared between the two groups. A special instrument, Peng's Multifunctional Operative Dissector, was used for surgical dissection. All tumors were resected successfully. One patient died of postoperative renal failure. Hydrothorax occurred in three patients, ascites occurred in four patients, and bile leakage occurred in one patient. Thirty cases received long-term follow-up with survival rates at 1, 3, and 5 years of 53%, 50%, and 39%, respectively. Caudate lobectomy is an effective therapeutic method for HCC originating in the caudate lobe. Isolated caudatectomy should be performed as the first choice whenever possible. Anterior transhepatic approach is appropriate in some cases. Peng's Multifunctional Operative Dissector is a very useful instrument for surgical dissection.
authors.affiliation: Department of Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, No. 88 Jie Fang Road, Hangzhou, Zhejiang Province, P. R. China 310009. zrwkpsy@zjuem.zju.edu.cn
authors.forename: Shu You
authors.initials: SY
authors.lastname: Peng
authors.forename: Jiang Tao
authors.initials: JT
authors.lastname: Li
authors.forename: Ying Bin
authors.initials: YB
authors.lastname: Liu
authors.forename: Xiu Jun
authors.initials: XJ
authors.lastname: Cai
authors.forename: Yi Ping
authors.initials: YP
authors.lastname: Mou
authors.forename: Xue Dong
authors.initials: XD
authors.lastname: Feng
authors.forename: Jian Wei
authors.initials: JW
authors.lastname: Wang
authors.forename: Bin
authors.initials: B
authors.lastname: Xu
authors.forename: Hao Ran
authors.initials: HR
authors.lastname: Qian
authors.forename: De Fei
authors.initials: DF
authors.lastname: Hong
authors.forename: Xin Bao
authors.initials: XB
authors.lastname: Wang
authors.forename: He Qing
authors.initials: HQ
authors.lastname: Fang
authors.forename: Li Ping
authors.initials: LP
authors.lastname: Cao
authors.forename: Li
authors.initials: L
authors.lastname: Chen
authors.forename: Chen Hong
authors.initials: CH
authors.lastname: Peng
authors.forename: Fu Bao
authors.initials: FB
authors.lastname: Liu
authors.forename: Jian Feng
authors.initials: JF
authors.lastname: Xue
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D005260:Female; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome